Sheng-Ming Dai Selected Research

Sheng-Ming Dai Research Topics

Disease

10	Rheumatoid Arthritis 02/2023 - 02/2004
8	Inflammation (Inflammations) 01/2023 - 02/2004
5	Experimental Arthritis 06/2015 - 11/2009
4	Ankylosing Spondylitis 02/2023 - 10/2012
4	Synovitis 01/2020 - 02/2004
3	Psoriatic Arthritis 11/2023 - 04/2020
3	Osteoarthritis 01/2022 - 09/2004
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2023 - 01/2021
2	COVID-19 05/2021 - 01/2020
2	Arthritis (Polyarthritis) 12/2020 - 09/2004
2	Pain (Aches) 01/2019 - 01/2011
1	Dermatitis 01/2023
1	Erectile Dysfunction 12/2022
1	Gout 12/2022
1	Axial Spondyloarthritis 01/2022
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022
1	Pneumonia (Pneumonitis) 05/2021
1	Joint Diseases (Joint Disease) 01/2021
1	Autoimmune Diseases (Autoimmune Disease) 04/2020
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2020
1	Infections 01/2020
1	Disease Progression 01/2019
1	Prostatic Neoplasms (Prostate Cancer) 10/2017
1	Lymphatic Metastasis 10/2017
1	Hyperplasia 05/2015
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2013
1	Bone Resorption 02/2013
1	Sepsis (Septicemia) 01/2013
1	Arthralgia (Joint Pain) 09/2012
1	Retinoblastoma (Glioblastoma, Retinal) 03/2006
1	Hypertension (High Blood Pressure) 02/2004

Drug/Important Bio-Agent (IBA)

4	CytokinesIBA 01/2022 - 11/2007
4	Cannabinoid Receptors (Cannabinoid Receptor)IBA 06/2015 - 01/2013
3	Interleukin-23 (Interleukin 23)IBA 01/2023 - 12/2020
3	Interleukin-18 (Interleukin 18)IBA 02/2013 - 02/2004
2	Interleukin-17 (Interleukin 17)IBA 11/2023 - 01/2022
2	tofacitinibIBA 02/2023 - 04/2020
2	C-Reactive ProteinIBA 02/2023 - 01/2019
2	baricitinibIBA 01/2022 - 04/2020
2	InterleukinsIBA 01/2022 - 11/2007
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2016 - 02/2004
2	peoniflorinIBA 09/2012 - 01/2011
1	AlbuminsIBA 02/2023
1	Indicators and Reagents (Reagents)IBA 02/2023
1	Interleukin-6 (Interleukin 6)IBA 01/2023
1	Imiquimod (Aldara)FDA LinkGeneric 01/2023
1	Sirtuin 3IBA 01/2023
1	Febuxostat FDA Link 12/2022
1	Allopurinol (Remid)FDA LinkGeneric 12/2022
1	Interferon Type IIBA 01/2022
1	InterferonsIBA 01/2022
1	Estrogens (Estrogen)FDA Link 01/2022
1	Prednisone (Sone)FDA LinkGeneric 01/2022
1	belimumabIBA 01/2022
1	tocilizumab (atlizumab)FDA Link 05/2021
1	Rheumatoid FactorIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2021
1	upadacitinibIBA 04/2020
1	Janus Kinase InhibitorsIBA 04/2020
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2020
1	Matrix Metalloproteinases (MMPs)IBA 01/2020
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2019
1	Celecoxib (Celebrex)FDA Link 01/2019
1	Messenger RNA (mRNA)IBA 10/2017
1	HU 308IBA 06/2015
1	CollagenIBA 06/2015
1	AutoantibodiesIBA 06/2015
1	AntibodiesIBA 06/2015
1	EndocannabinoidsIBA 05/2015
1	EnzymesIBA 05/2015
1	LigandsIBA 05/2015
1	Tumor Necrosis Factor InhibitorsIBA 11/2013
1	LipopolysaccharidesIBA 01/2013
1	Therapeutic UsesIBA 09/2012
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 05/2011
1	Methotrexate (Mexate)FDA LinkGeneric 05/2011
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 05/2011
1	Analgesics (Analgesic Drugs)IBA 01/2011
1	CalciumIBA 01/2011
1	Adenosine A1 ReceptorIBA 01/2011
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2011
1	Leukotriene B4IBA 01/2011
1	Dinoprostone (PGE2)FDA Link 01/2011
1	HMGB1 Protein (HMG1)IBA 11/2009
1	ChemokinesIBA 11/2007
1	CaveolinsIBA 03/2006
1	p38 Mitogen-Activated Protein KinasesIBA 03/2006
1	Caveolin 1IBA 03/2006
1	15-deoxy-delta(12,14)-prostaglandin J2IBA 09/2004
1	PPAR gammaIBA 09/2004
1	Arginine Vasopressin (Argipressin)IBA 02/2004
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 02/2004
1	Interleukin-1beta (Interleukin 1 beta)IBA 02/2004
1	Interleukin-1 (Interleukin 1)IBA 02/2004
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 02/2004
1	beta-Endorphin (Endorphin, beta)IBA 02/2004
1	Leucine EnkephalinIBA 02/2004

Therapy/Procedure

4	Therapeutics 01/2022 - 05/2011
1	Intra-Articular Injections 11/2009